Usefulness of SWI for the Detection of Iron in the Motor Cortex in Amyotrophic Lateral Sclerosis

Journal of Neuroimaging

Volumn 25, Issue 3, 2015, Pages 443-451

  Adachi, Yuko ^a   Sato, Noriko ^a   Saito, Yuko ^a   Kimura, Yukio ^a   Nakata, Yasuhiro ^a   Ito, Kimiteru ^a   Kamiya, Kouhei ^a   Matsuda, Hiroshi ^a   Tsukamoto, Tadashi ^a   Ogawa, Masahumi ^a  

^a Department of Adult Mental Health National Institute of Mental Health National Center of Psychiatry and Neurology   (Japan)

Author keywords

Alprostadil; Erectile dysfunction; Prostate cancer; Validation

Indexed keywords

FERRITIN ANTIBODY; IRON; BIOLOGICAL MARKER; SPIN LABELING;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; INTERMETHOD COMPARISON; MACROPHAGE; MALE; MICROGLIA; MOTOR CORTEX; NUCLEAR MAGNETIC RESONANCE SCANNER; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SUSCEPTIBILITY WEIGHTED IMAGING; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; IRON OVERLOAD; METABOLISM; MIDDLE AGED; MOLECULAR IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPIN LABELING; TISSUE DISTRIBUTION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOMARKERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; IRON OVERLOAD; MALE; MIDDLE AGED; MOLECULAR IMAGING; MOTOR CORTEX; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPIN LABELS; TISSUE DISTRIBUTION;

EID: 84929024756     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12127     Document Type: Article

References (41)

1. Benatar M. Neuromuscular Disease: Evidence and Analysis in Clinical Neurology. Totowa, New Jersey: Humana Press Inc, 2006:43-58.
2. Lerner AJ. Diagnostic Criteria in Neurology. Totowa, New Jersey: Humana Press Inc, 2006:183-191.
3. Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843-846.
4. Agosta F, Pagani E, Petrolini M, et al. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci 2010;32:1490-1496.
5. Chan S, Shungu DC, Douglas-Akinwande A, et al. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999;212:763-769.
6. Govind V, Sharma KR, Maudsley AA, Arheart KL, et al. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PLoS One 2012;7:e35607.
7. Agosta F, Pagani E, Petrolini M, et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol 2010;31:1457-1461.
8. Wang S, Poptani H, Bilello M, et al. Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 2006;27:1234-1238.
9. Canu E, Agosta F, Riva N, Sala S, et al. The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am J Neuroradiol 2011;32:1307-1314.
10. Cirillo M, Esposito F, Tedeschi G, Caiazzo G, et al. Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol 2012;33:1102-1108.
11. Sarro L, Agosta F, Canu E, Riva N, et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am J Neuroradiol 2011;32:1866-1872.
12. Carrara G, Carapelli C, Venturi F, Ferraris MM, et al. A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol 2011;33:733-739.
13. Welsh RC, Jelsone-Swain LM, Foerster BR. The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain. Front Hum Neurosci 2013;10:251.
14. Turner MR, Modo M. Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn 2010;4:438-496.
15. Sharma KR, Sheriff S, Maudsley A, et al. Diffusion tensor imaging of Basal Ganglia and thalamus in amyotrophic lateral sclerosis. J Neuroimaging 2013;23:368-374.
16. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165-171.
17. Kim JK, Kucharczyk W, Henkelman RM. Cavernous hemangiomas: dipolar susceptibility artifacts at MR imaging. Radiology 1993;187:735-741.
18. Atlas SW, Mark AS, Grossman RI, et al. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988;168:803-807.
19. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19-30.
20. Nandigam RN, Viswanathan A, Delgado P, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009;30:338-343.
21. de Souza JM, Domingues RC, Cruz LC, Jr., et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008;29:154-158.
22. Haque TL, Miki Y, Kanagaki M, et al. MR contrast of ferritin and hemosiderin in the brain: comparison among gradient-echo, conventional spin-echo and fast spin-echo sequences. Eur J radiol 2003;48:230-236.
23. Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on Motor Neuron Diseases.El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
24. Iwasaki S, Nakagawa H, Fukusumi A, et al. Identification of pre- and postcentral gyri on CT and MR images on the basis of the medullary pattern of cerebral white matter. Radiology 1991;179:207-213.
25. Adachi T, Saito Y, Hatsuta H, et al. Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol 2010;69:737-744.
26. Kwan JS, Van Gelderen P, Deng HX, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 2012;7:e35241.
27. Vymazal J, Righini A, Brooks RA, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999;211:489-495.
28. Jellinger KA. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease. Drugs aging 1999;14:115-140.
29. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 1998;27:257-267.
30. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-1293.
31. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000;11:15-21.
32. Wu EX, Kim D, Tosti CL, et al. Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron. Ann N Y Acad Sci 2010;1202:115-122.
33. Tao R, Zhang J, Dai Y, et al. An in vitro and in vivo analysis of the correlation between susceptibility-weighted imaging phase values and R2* in cirrhotic livers. PloS One 2012;7:e45477.
34. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-618.
35. Chamberlain R, Reyes D, Curran GL, et al. Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease. Magn Reson Med 2009;61:1158-1164.
36. Pfefferbaum A, Adalsteinsson E, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009;47:493-500.
37. Harder SL, Hopp KM, Ward H, et al. Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176-183.
38. Haacke EM, Miao Y, Liu M, et al. Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J Magn Reson imaging 2010;32:561-576.
39. de Rochefort L, Brown R, Prince MR, et al. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn Reson Med 2008;60:1003-1009
40. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63:194-206
41. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson imaging 2009;29:537-544.